Report Categories Report Categories

Report Categories

industry Category

All

Total: 5 records, 1 pages

Global Hepatocellular Carcinoma Targeted Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

date 13 Jan 2025

date Pharma & Healthcare

new_biaoQian Hepatocellular Carcinoma Targeted Drug

According to our (Global Info Research) latest study, the global Hepatocellular Carcinoma Targeted Drug market size was valued at US$ 1005 million in 2024 and is forecast to a readjusted size of USD 1671 million by 2031 with a CAGR of 7.6% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Hepatocellular Carcinoma Targeted Drug Supply, Demand and Key Producers, 2024-2030

date 24 Feb 2024

date Pharma & Healthcare

new_biaoQian Hepatocellular Carcinoma Targeted Drug

The global Hepatocellular Carcinoma Targeted Drug market size is expected to reach $ 1439.2 million by 2030, rising at a market growth of 7.5% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global Hepatocellular Carcinoma Targeted Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 05 Jan 2024

date Pharma & Healthcare

new_biaoQian Hepatocellular Carcinoma Targeted Drug

According to our (Global Info Research) latest study, the global Hepatocellular Carcinoma Targeted Drug market size was valued at USD 869.5 million in 2023 and is forecast to a readjusted size of USD 1439.2 million by 2030 with a CAGR of 7.5% during review period.

USD3480.00

Add To Cart

Add To Cart

Global Hepatocellular Carcinoma Targeted Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 06 Feb 2023

date Pharma & Healthcare

new_biaoQian Hepatocellular Carcinoma Targeted Drug

The most effective targeted drug introduced for HCC has been sorafenib. Sorafenib, a multi-tyrosine kinase inhibitor (TKI), remains the only systemic targeted tumor therapy in use for advanced HCC (18-21).

USD3480.00

Add To Cart

Add To Cart

Global Hepatocellular Carcinoma Targeted Drug Supply, Demand and Key Producers, 2023-2029

date 03 Feb 2023

date Pharma & Healthcare

new_biaoQian Hepatocellular Carcinoma Targeted Drug

The global Hepatocellular Carcinoma Targeted Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

industry 13 Jan 2025

industry Pharma & Healthcare

new_biaoQian Hepatocellular Carcinoma Targeted Drug

According to our (Global Info Research) latest study, the global Hepatocellular Carcinoma Targeted Drug market size was valued at US$ 1005 million in 2024 and is forecast to a readjusted size of USD 1671 million by 2031 with a CAGR of 7.6% during review period.

USD3480.00

addToCart

Add To Cart

industry 24 Feb 2024

industry Pharma & Healthcare

new_biaoQian Hepatocellular Carcinoma Targeted Drug

The global Hepatocellular Carcinoma Targeted Drug market size is expected to reach $ 1439.2 million by 2030, rising at a market growth of 7.5% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 05 Jan 2024

industry Pharma & Healthcare

new_biaoQian Hepatocellular Carcinoma Targeted Drug

According to our (Global Info Research) latest study, the global Hepatocellular Carcinoma Targeted Drug market size was valued at USD 869.5 million in 2023 and is forecast to a readjusted size of USD 1439.2 million by 2030 with a CAGR of 7.5% during review period.

USD3480.00

addToCart

Add To Cart

industry 06 Feb 2023

industry Pharma & Healthcare

new_biaoQian Hepatocellular Carcinoma Targeted Drug

The most effective targeted drug introduced for HCC has been sorafenib. Sorafenib, a multi-tyrosine kinase inhibitor (TKI), remains the only systemic targeted tumor therapy in use for advanced HCC (18-21).

USD3480.00

addToCart

Add To Cart

industry 03 Feb 2023

industry Pharma & Healthcare

new_biaoQian Hepatocellular Carcinoma Targeted Drug

The global Hepatocellular Carcinoma Targeted Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart